NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.89% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 5.45% |
| ZBH | Zimmer Biomet Holdings Inc | Healthcare | Medical Devices | 4.23% |
| DUK | Duke Energy Corporation | Utilities | Utilities - Regulated Electric | 4.19% |
| ATO | Atmos Energy Corporation | Utilities | Utilities - Regulated Gas | 3.76% |
| PG | Procter & Gamble Company | Consumer Defensive | Household & Personal Products | 3.74% |
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 3.64% |
| UL | Unilever PLC ADR | Consumer Defensive | Household & Personal Products | 3.54% |
| NSC | Norfolk Southern Corporation | Industrials | Railroads | 3.45% |
| CL | Colgate-Palmolive Company | Consumer Defensive | Household & Personal Products | 3.39% |
| UPS | United Parcel Service Inc | Industrials | Integrated Freight & Logistics | 3.38% |
| TTE | TotalEnergies SE ADR | Energy | Oil & Gas Integrated | 3.01% |
| RGA | Reinsurance Group of America | Financial Services | Insurance - Reinsurance | 2.87% |
| JPM | JPMorgan Chase & Co | Financial Services | Banks - Diversified | 2.86% |
| KMB | Kimberly-Clark Corporation | Consumer Defensive | Household & Personal Products | 2.64% |
| TFC | Truist Financial Corp | Financial Services | Banks - Regional | 2.64% |
| DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 2.62% |
| HSIC | Henry Schein Inc | Healthcare | Medical Distribution | 2.5% |
| BRK-B | Berkshire Hathaway Inc | Financial Services | Insurance - Diversified | 2.28% |
| KVUE | Kenvue Inc. | Consumer Defensive | Household & Personal Products | 2.24% |
Under normal market conditions, the portfolio managers will invest at least 80% of the fund's assets in securities of large capitalization companies. The portfolio managers may sell stocks from the fund's portfolio if they believe a stock no longer meets their valuation criteria, a stock's risk parameters outweigh its return opportunity, more attractive alternatives are identified or specific events alter a stock's prospects.